Market News

Breaking headlines and analysis across every asset class.

Markets
Investing.com Canada • Oct 1, 2026
B.Riley reiterates Kymera Therapeutics stock rating on new trial data

B.Riley has reiterated a Buy rating and a $155.00 price target for Kymera Therapeutics (NASDAQ: KYMR) after the company presented new data from its oral STAT6 degrader KT-621 at EADV’26. The stock has seen a 104% increase over the past year, reflecting strong investor interest. Several other analysts, including Stifel, BofA Securities, Guggenheim, and Piper Sandler, have also recently increased their price targets and maintained Buy or Overweight ratings, indicating broad positive sentiment driv

Markets
The Manila Times • Oct 1, 2026
KBR Publicly Files Form 10 Registration Statement for Planned Spin-off Company Trinzic

KBR announced it has publicly filed a Form 10 registration statement with the SEC for the planned spin-off of its Mission Technology Solutions (MTS) business, which will operate as Trinzic and trade on the NYSE as TZIC. The separation is expected in January 2027, positioning Trinzic as a global provider of mission-critical solutions for national security, defense, and space. Both KBR and Trinzic will host Investor Days in November 2026.

Markets
Investing.com Canada • Oct 1, 2026
Form 4 Kayne Anderson BDC For: 1 October By Investing.com

This article from Investing.com reports on a Form 4 filing for Kayne Anderson BDC, dated October 1. The brief mention indicates a financial transaction or disclosure related to the company. The article provides no further details beyond the filing's existence and date.

Markets
Stock Titan • Oct 1, 2026
After selling 49,064 shares, a 10% holder proposes another Hinge Health (HNGE) share sale.

Insight Venture Partners (Delaware) X, L.P., a 10% stockholder in Hinge Health, Inc. (HNGE), has proposed selling 77,248 Class A shares valued at $7,570,304, with an approximate sale date of September 30, 2026. This notice follows recent sales by the same entity, including 49,064 Class A shares on August 10, 2026, for over $4.4 million. Raymond James & Associates, Inc. is identified as the broker for this proposed transaction.

Markets
Stock Titan • Oct 1, 2026
After six sales, a 10% holder proposes another share sale at Hinge Health (HNGE).

Insight Venture Partners X, L.P., a 10% stockholder of Hinge Health, Inc. (HNGE), has proposed to sell 486,991 Class A shares valued at approximately $47.7 million, with an approximate sale date of September 30, 2026. This proposed sale follows six previous sales by the same partnership within the past three months, totaling over 700,000 shares. The Form 144 filing provides details on the securities to be sold, the acquisition history, and the previous sales made by the insider.

Markets
Stock Titan • Oct 1, 2026
A 10% stockholder plans a Hinge Health (HNGE) share sale through Raymond James.

Insight Venture Partners (Cayman) X, L.P., a 10% stockholder in Hinge Health, Inc. (HNGE), plans to sell 399,338 Class A shares valued at approximately $39.1 million through Raymond James & Associates, Inc. The approximate sale date is September 30, 2026. This notice also details six prior Class A share sales by the same stockholder between July 7 and August 10, 2026.

Markets
Stock Titan • Oct 1, 2026
A fund reports 1.1M shares in i3 Verticals (IIIV), a passive position above 5%.

Forager Fund, L.P., along with its general partner Forager Capital Management, LLC, Edward Kissel, and Robert MacArthur, has reported a collective beneficial ownership of 1,106,474 shares of i3 Verticals, Inc. (IIIV) Class A common stock, representing a 6.1% passive stake. This ownership is based on 18,019,748 shares outstanding as of August 6, 2026. The filing indicates sole voting and dispositive power for the fund and its general partner, while Kissel and MacArthur share voting and dispositiv

Markets
Investing.com UK • Oct 1, 2026
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com

This article reports on the filing of Form 144 by Kestra Medical Technologies for October 1st. It briefly mentions the company's stock symbol KMTS and provides a snapshot of current stock market performance for major indices, commodities, bonds, and selected shares. The piece is part of a financial news compilation from Investing.com.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.